{"id":4168,"date":"2014-10-17T10:00:31","date_gmt":"2014-10-17T14:00:31","guid":{"rendered":"http:\/\/me-en.kaspersky.com\/blog\/?p=4168"},"modified":"2020-02-26T18:59:06","modified_gmt":"2020-02-26T14:59:06","slug":"wonders_of_whitelisting","status":"publish","type":"post","link":"https:\/\/me-en.kaspersky.com\/blog\/wonders_of_whitelisting\/4168\/","title":{"rendered":"The Wonders of Whitelisting (as Opposed to Blacklisting)"},"content":{"rendered":"

As it\u2019s most popularly understood, malware protection relies upon signature detection. However, detecting malicious software is only one side of the antivirus coin. In fact, some would say signature-based detection \u2013 essentially a form of blacklisting \u2013 is the less significant side of that coin. On the other side there is whitelisting, or the pre-approval of harmless software as opposed to the blocking of harmful software.<\/p>\n

\"KIS-Fortifying-your-PC\"<\/a><\/p>\n

What is Blacklisting?<\/strong><\/p>\n

Allow me to explain this through the prism of specific Kaspersky technology: the Kaspersky Security Network<\/a> (KSN). When users install certain Kaspersky Lab products, they are offered the opportunity to willingly join the KSN. Should they decide to opt-in, they become part of a distributed infrastructure dedicated to processing cybersecurity-related information. If an opted-in user in India becomes infected with a new type of malware, Kaspersky Lab creates a signature to detect that malware, and then adds that signature<\/a> to its database so that no other Kaspersky user will become infected with that malware.<\/p>\n